RETRACTION: Vitamin D Alleviates Cognitive Dysfunction by Activating the VDR/ERK1/2 Signaling Pathway in an Alzheimer's Disease Mouse Model (Retraction of Vol 27, Pg 178, 2021)

被引：0
|
作者：
Bao, Zheng
Wang, Xue
Li, Yuhong
Feng, Fumin
机构：
来源：
NEUROIMMUNOMODULATION | 2024年 / 31卷 / 01期
关键词：
D O I：
10.1159/000538504
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：65 / 65
页数：1
相关论文
共 33 条
  • [1] Vitamin D Alleviates Cognitive Dysfunction by Activating the VDR/ERK1/2 Signaling Pathway in an Alzheimer's Disease Mouse Model
    Bao, Zheng
    Wang, Xue
    Li, Yuhong
    Feng, Fumin
    NEUROIMMUNOMODULATION, 2021, 27 (04) : 178 - 185
  • [2] The developmental pattern of the RAS/RAF/Erk1/2 pathway in the BTBR autism mouse model (Retraction of vol 39, pg 2, 2014)
    Yin, Ailan
    Qiu, Yuwen
    Beijia
    Song, Tianrong
    Yu, Yanhong
    Alberts, Ian
    Zhong, Mei
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2015, 44 : 102 - 102
  • [3] RETRACTION: XBP1S protects cells from ER stress-induced apoptosis through Erk1/2 signaling pathway involving CHOP (Retraction of Vol 138, Pg 447, 2021)
    Guo, Feng-Jin
    Liu, Yanna
    Zhou, Jinghua
    Luo, Suxin
    Zhao, Wenjun
    Li, Xiangzhu
    Liu, Chuanju
    HISTOCHEMISTRY AND CELL BIOLOGY, 2021, 156 (02) : 191 - 191
  • [4] RETRACTION: Neuroprotection of chromobox seven knockout in the mouse after cerebral ischemia-reperfusion injury via nuclear factor E2-related factor 2/hemeoxygenase-1 signaling pathway (vol 40, pg S178, 2021) (Retraction of Vol 40, Pg S178, 2021)
    不详
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2022, 41
  • [5] RETRACTION: Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease (Retraction of Vol 68, Pg 59, 2018)
    Belfiore, Antonella Caccamoa Ramona
    Oddo, Salvatore
    NEUROBIOLOGY OF AGING, 2021, 104 : 139 - 139
  • [6] RETRACTION: Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling (vol 40, pg 922, 2021) (Retraction of Vol 40, Pg 922, 2021)
    Lu, Jun
    Bang, Heejin
    Kim, Su Mi
    Cho, Soo-Jeong
    Ashktorab, Hassan
    Smoot, Duane T.
    Zheng, Chao-hui
    Ryeom, Sandra W.
    Yoon, Sam S.
    Yoon, Changhwan
    Lee, Jun Ho
    ONCOGENE, 2024, 43 (11) : 837 - 837
  • [7] RETRACTION: 5-Lipoxygenase Activating Protein Reduction Ameliorates Cognitive Deficit, Synaptic Dysfunction, and Neuropathology in a Mouse Model of Alzheimer's Disease
    Giannopoulos, Phillip F.
    Chu, Jin
    Joshi, Yash B.
    Sperow, Margaret
    Li, Jin-Guo
    Kirby, Lynn G.
    Pratico, Domenico
    BIOLOGICAL PSYCHIATRY, 2024, 96 (02) : 160 - 160
  • [8] ORIGINAL RESEARCH Leonurine Alleviates Cognitive Dysfunction and Reduces Oxidative Stress by Activating Nrf-2 Pathway in Alzheimer's Disease Mouse Model
    Xie, Yue
    Jin, Yaning
    Li, Shuyue
    Shen, Baoxi
    Ma, Liping
    Zuo, Lujie
    Gao, Ya
    Yang, Guofeng
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 1347 - 1357
  • [9] RETRACTION: Roflumilast and tadalafil improve learning and memory deficits in intracerebroventricular Aβ1-42 rat model of Alzheimer's disease through modulations of hippocampal cAMP/cGMP/BDNF signaling pathway (vol 73, pg 1287, 2021) (Retraction of Vol 73, Pg 1287, 2021)
    Hasan, Noorul
    Zameer, Saima
    Najmi, Abul Kalam
    Parvez, Suhel
    Yar, Mohammad Shahar
    Akhtar, Mohd
    PHARMACOLOGICAL REPORTS, 2023, 75 (05) : 1309 - 1309
  • [10] RETRACTION: Mineralocorticoid Receptor Antagonist-Mediated Cognitive Improvement In A Mouse Model Of Alzheimer's Type: Possible Involvement Of BDNF-H2S-Nrf2 Signaling (Retraction of Vol 34, Pg 697, 2020)
    Chen, L.
    Shi, R.
    She, X.
    Gu, C.
    Chong, L.
    Zhang, L.
    Li, R.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2025, 39
1234